Day: March 5, 2026

Maris-Tech Strengthens Defense Foothold with First Substantial Order from a Leading Defense Loitering Munitions Manufacturer

Written by Customer Service on March 5, 2026. Posted in Public Companies.

This order marks the transition to operational supply of Jupiter Drone edge video processing systems for defense applications Rehovot, Israel, March 05, 2026 (GLOBE NEWSWIRE) — Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a global leader in video and artificial intelligence (“AI”)-based edge computing technology, announced on February 19, 2026, that it has received its first substantial production order from a new customer, which is a dominant player in the defense loitering munitions sector. The order follows the successful completion of pilot projects with the customer and initial system validation, marking the first substantial operational supply order. The production order reflects the customer’s move from evaluation to operational deployment, which the Company believes demonstrates the maturity,...

Independent Proxy Advisory Firms, Including ISS, Recommend Bitfarms Shareholders Vote FOR U.S. Redomiciliation

Written by Customer Service on March 5, 2026. Posted in Public Companies.

Recommendation Highlights Compelling Strategic Rationale for U.S. Redomiciliation Board of Directors Encourages Shareholders to Vote FOR the Arrangement Resolution Today TORONTO, Ontario and NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) — Bitfarms Ltd. (NASDAQ/TSX: BITF) (“Bitfarms” or the “Company”), a North American digital infrastructure and energy company, today announced that the leading independent proxy advisory firms, including Institutional Shareholder Services Inc. (“ISS”), have recommended shareholders vote FOR the special resolution (the “Arrangement Resolution”) to approve Bitfarms’ U.S. redomiciliation (the “U.S. Redomiciliation”) ahead of the Company’s upcoming special meeting of shareholders (the “Meeting”) to be held at 9:00 a.m. (Eastern Time) on March 20, 2026. In its report, ISS noted*: “The company presents a strong...

Concentrix Schedules Release of First Quarter 2026 Financial Results and Investor Conference Call Webcast

Written by Customer Service on March 5, 2026. Posted in Public Companies.

NEWARK, Calif., March 05, 2026 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, today announced plans to release its first quarter 2026 financial results before market open on Tuesday, March 24, 2026. The company also plans to host a conference call and webcast with the investment community later that morning Tuesday, March 24, 2026, at 8:30 a.m. Eastern Time to discuss its first quarter financial results and to answer analyst questions. The live conference call webcast will be available in listen-only mode in the Investor Relations section of the Concentrix website under “Events and Presentations.” A replay will also be available on the website following the conference call. About us: Powering a World That WorksConcentrix Corporation (NASDAQ: CNXC), a Fortune 500® company, is the...

NTG Nordic Transport Group A/S – Notice to convene the Annual General Meeting 2026

Written by Customer Service on March 5, 2026. Posted in Public Companies.

Company announcement no. 4 – 26 5 March 2026 NTG Nordic Transport Group A/S – Notice to convene the Annual General Meeting 2026 The Annual General Meeting of NTG Nordic Transport Group A/S will be held on Friday, 27 March 2026, at 14:00 (CET) at Glostrup Park Hotel, Hovedvejen 41, 2600 Glostrup, Denmark. The notice to convene the Annual General Meeting including Appendix 1 and Appendix 2 is attached. Additional information For additional information, please contact:Sebastian Rosborg, Head of Investor Relations +45 42 12 80 99ir@ntg.comPernille Skov Korsager, Group General Counsel +45 20 23 32 19pko@ntg.comAttachments Notice to convene Annual General Meeting 2026 of NTG Appendix 1 Appendix 2 Company announcement no. 4-26AttachmentsNotice to convene AGM, including agenda and...

Orbit International Reports Consolidated Bookings for Month of February 2026 in Excess of $2,100,000

Written by Customer Service on March 5, 2026. Posted in Public Companies.

FIRM BOOKINGS OF APPROXIMATELY $1,000,000 FOR FEBRUARY 2026 FROM SIMULATOR PRODUCT SOLUTIONS LLC SUBSIDIARY ALSO FIRM BOOKINGS FROM ORBIT POWER GROUP ON STRONG VPX BOOKINGS FOR FEBRUARY 2026 HAUPPAUGE, N.Y., March 05, 2026 (GLOBE NEWSWIRE) — Orbit International Corp. (the “Company”) (OTCID Basic Market:ORBT), an electronics manufacturer and software solution provider, today announced that consolidated bookings for the month of February 2026 were in excess of $2,100,000. The firm bookings for the month of February 2026 were primarily attributable to bookings recorded by both its Orbit Electronics Group (“OEG”) and its Orbit Power Group (“OPG”). Deliveries for orders received during the month have already commenced and are expected to continue through the first quarter of 2027. Mitchell Binder, President and CEO of Orbit International...

Autonomix Medical Selected for Best Innovation Competition at CRT 2026

Written by Customer Service on March 5, 2026. Posted in Public Companies.

THE WOODLANDS, TX, March 05, 2026 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that its presentation titled, “Illuminating The Nervous System With Transvascular Precision-guided Technology,” has been selected for oral presentation in the Best Innovation Competition at Cardiovascular Research Technologies (CRT) 2026. The presentation will be delivered by Chief Executive Officer, Brad Hauser, on Monday, March 9, 2026, from 4:19 PM to 4:27 PM ET in the International Ballroom – West. The CRT Best Innovation Competition highlights transformative technologies with the potential to meaningfully impact patient care. Selection for oral presentation reflects the program’s emphasis on scientific...

High Roller Technologies Schedules Conference Call to Discuss Fourth Quarter 2025 Financial Results and Business Update

Written by Customer Service on March 5, 2026. Posted in Public Companies.

Las Vegas, Nevada, March 05, 2026 (GLOBE NEWSWIRE) — High Roller Technologies, Inc. (“High Roller”) (NYSE: ROLR), operator of the award-winning, premium online casino brands High Roller and Fruta, today announced that the Company will host a conference call regarding its fourth quarter 2025 financial results and business update on Tuesday, March 10, 2026 at 4:30 PM Eastern Time (ET). To join the live conference call, please dial 877-407-6176 (U.S. and Canadian callers) or +1 201-689-8451 (international callers outside of the U.S. and Canada) 10 to 15 minutes prior to the scheduled call time. Participants can also click this link for instant telephone access to the event. The link will become active approximately 15 minutes prior to the start of the conference call. The conference ID# is 13758953. Participating on the call will...

Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results

Written by Customer Service on March 5, 2026. Posted in Earnings Releases And Operating Results.

SOUTH SAN FRANCISCO, Calif., March 05, 2026 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today reported recent business progress and financial results for the fourth quarter and full year 2025. “Our team has made tremendous progress recently in the global Phase 2 B-SUPREME study of pevifoscorvir sodium,” stated Lawrence Blatt, Ph.D., M.B.A., Chairman, President, and Chief Executive Officer of Aligos Therapeutics. “With the completion of the planned enrollment in the HBeAg- cohort, we are continuing to enroll participants in the HBeAg+ cohort and look forward to the interim analyses in the first and second half of 2026. Additionally, the Phase 2 B-SUPREME study may demonstrate...

Remote Monitoring and Control Provider Acorn Reports Higher 2025 Revenue and Operating Income, Benefiting from a 22% Increase in Monitoring Revenue and a Related Gross Margin Increase

Written by Customer Service on March 5, 2026. Posted in Earnings Releases And Operating Results.

WILMINGTON, Del., March 05, 2026 (GLOBE NEWSWIRE) — Acorn Energy, Inc. (Nasdaq: ACFN), provider of remote monitoring and control solutions for critical infrastructure assets, announced results for its fourth quarter (Q4’25) and full-year ended December 31, 2025. Acorn will hold an investor call today at 11 a.m. ET (details below).Summary Financial Results ($ in thousands) Q4’25 Q4’24 Change 2025 2024 ChangeMonitoring revenue $ 1,411 $ 1,203 +17.3 % $ 5,560 $ 4,553 +22.1 %Hardware revenue $ 966 $ 2,326 -58.5 % $ 5,918 $ 6,433 -8.0 %Total revenue(1) $ 2,377 $ 3,529 -32.6 % $ 11,478 $ 10,986 +4.5 %Gross margin 80.1 % 72.4 % +770 bps 76.8 % 72.8 % +400 bpsNet income to stockholders (2) $ 1,074 $ 5,233 -79.5 % $ 2,510 $ 6,294 -60.1 %Diluted...

Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update

Written by Customer Service on March 5, 2026. Posted in Earnings Releases And Operating Results.

In the Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with biliary tract cancer, the prespecified event threshold of 80% overall survival (OS) events was reached in Q1 2026; as a result, the analyses of progression-free survival (PFS) and OS are expected to be reported in April. Based on previously reported responses in patients with triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC) in the Phase 1 study of CTX-8371 (PD-1 x PD-L1 bispecific antibody), expansion cohorts are now open and enrolling patients with these tumor types; based on an additional response in a patient with Hodgkin lymphoma, a further expansion cohort of patients with Hodgkin lymphoma will begin shortly. The IND application for CTX-10726 (PD-1 x VEGF-A bispecific antibody) received FDA clearance...

Day: March 5, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals